Finally, we constructed a signature comprising genes that were specifically regulated by BMP4 in the absence of SMAD4 and found that this signature is increasingly represented in high-grade breast tumors (Fig. 6e) and predicts significantly worse overall survival (Fig. 6f) in the Metabric patient dataset. Here, BMP4 is linked to breast neoplasm.